Cusabio) Lambda, Delta and More: Quality Mutant Proteins Facilitate Your SARS-CoV-2 Research!
ÀÛ¼ºÀÚ
abbabio
ÀÛ¼ºÀÏÀÚ
2021-09-08
Á¶È¸¼ö
336
If you are unable to see the message below, click here to view.
The global COVID-19 pandemic still rages around the world. It is well-known that the SARS-CoV-2 has an astonishing speed of mutation. It took just over a year to use nearly 1/2 of the Greek alphabet, and developed from Alpha to Lambda. Subsequently, the new variants spread like Beta in South Africa, Delta in India, and Lambda in Peru. CUSABIO produced the most popular mutant antigens, which will meet needs in diverse COVID-19 research in clinical and research labs.
As the COVID-19 pandemic evolves, we are with you during these turbulent times. CUSABIO appreciates the critical role that you and our products play in research efforts to further scientific innovation and discovery. We know that many scientists are diligently pursuing their research throughout the pandemic. Our customer service and technical support teams are equipped to remain available to help with your research needs and answer any questions.